Kamada Ltd. Share Price TEL AVIV STOCK EXCHANGE
Stocks
IL0010941198
Pharmaceuticals
| Market Cap | 1.28B 418M 364M 339M 311M 587M 39.94B 596M 3.99B 1.57B 19.89B 1.57B 1.54B 66.68B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 1.28B 418M 364M 339M 311M 587M 39.94B 596M 3.99B 1.57B 19.89B 1.57B 1.54B 66.68B | EV / Sales 2026 * |
2.14x | EV / Sales 2027 * | 1.96x |
| Free-Float |
54.51% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Kamada Ltd.
| 1 day | -0.53% |
| Manager | Title | Age | Since |
|---|---|---|---|
Amir London
CEO | Chief Executive Officer | 57 | 30/06/2015 |
Chaime Orlev
DFI | Director of Finance/CFO | 55 | 30/12/2017 |
Eran Nir
COO | Chief Operating Officer | 53 | 31/10/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
David Tsur
BRD | Director/Board Member | 75 | 12/12/1990 |
Leon Recanati
CHM | Chairman | 77 | 06/03/2013 |
| Chairman | 55 | 11/08/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.53% | -1.28% | - | - | 418M | |
| +3.29% | +16.25% | +39.81% | +2.79% | 76.15B | |
| -2.75% | +48.50% | +48.50% | +48.50% | 47.83B | |
| +2.72% | -9.39% | +17.04% | +176.83% | 48.89B | |
| -3.81% | +7.74% | -54.57% | -54.17% | 41.37B | |
| -2.40% | +0.38% | +58.55% | -24.89% | 29.99B | |
| -2.82% | +1.57% | +59.59% | +87.57% | 24.23B | |
| -5.35% | +1.39% | +85.45% | -53.41% | 21.75B | |
| -1.59% | -3.61% | -11.53% | +150.58% | 19.25B | |
| -0.42% | +2.89% | +74.55% | +128.45% | 17.14B | |
| Average | -1.74% | +1.48% | +35.27% | +51.36% | 36.29B | |
| Weighted average by Cap. | -1.49% | +2.98% | +30.74% | +43.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 600M 196M 170M 158M 145M 275M 18.69B 279M 1.87B 733M 9.3B 735M 719M 31.2B | 655M 213M 186M 173M 159M 299M 20.38B 304M 2.04B 799M 10.15B 802M 784M 34.02B |
| Net income | 73.89M 24.1M 20.95M 19.5M 17.9M 33.81M 2.3B 34.33M 230M 90.21M 1.15B 90.51M 88.52M 3.84B | 105M 34.39M 29.89M 27.82M 25.54M 48.24M 3.28B 48.99M 328M 129M 1.63B 129M 126M 5.48B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
